Search
for
Sort by
Research 451–480 of 1000+
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- The role of janus kinases in the treatment of autoimmune skin diseases
- A New Immune-Biochemical Study To Identify Indicators Of The Response Of Infertile Polycystic Ovary Syndrome Patients To Metformin Treatment
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- 608 A clinical study to test the efficacy of VB1953 in clindamycin non-responder acne patients with antibiotic-resistant P. acnes
- Complex Changes in the Apoptotic and Cell Differentiation Programs during Initiation of the Hair Follicle Response to Chemotherapy
- γδ17 T cell-stromal networks modulate matrix composition and vascularity in foreign body response
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- 598 Response to ritlecitinib treatment based on salt improvement scores in patients with alopecia areata (AA): Post hoc analysis of the allegro phase 2b/3 study
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- Concomitant presentation of alopecia areata in siblings: A rare occurrence
- Case report of novel combination of anthralin and calcipotriene leading to trichologic response in alopecia areata
- Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
- Alopecia and autoimmune thyroiditis: the role of selenium and zinc
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Lichenoid red tatoo reaction and alopecia areata
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- Deficiency Pattern and Responsiveness in Clinical Settings in Discovering the Correlation between Vitamin D Analogues and Hair Growth in Alopecia Areata
- Cutaneous reactions to recombinant cytokine therapy
- Alopecia areata: diagnosis and management
- Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity
- Alopecia areata: An update
- Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome
- What′s new in cicatricial alopecia?
- Frontal fibrosing alopecia and lichen planopilaris in HLA-identical mother and daughter
- Retinoids Putting the “A” in Alopecia
- Alopecia in Cronkhite–Canada syndrome: Is it truly telogen effluvium?